全文获取类型
收费全文 | 1986篇 |
免费 | 124篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 30篇 |
妇产科学 | 29篇 |
基础医学 | 304篇 |
口腔科学 | 178篇 |
临床医学 | 134篇 |
内科学 | 476篇 |
皮肤病学 | 32篇 |
神经病学 | 199篇 |
特种医学 | 27篇 |
外科学 | 142篇 |
综合类 | 1篇 |
预防医学 | 148篇 |
眼科学 | 43篇 |
药学 | 182篇 |
中国医学 | 21篇 |
肿瘤学 | 102篇 |
出版年
2024年 | 3篇 |
2023年 | 16篇 |
2022年 | 50篇 |
2021年 | 83篇 |
2020年 | 45篇 |
2019年 | 69篇 |
2018年 | 92篇 |
2017年 | 48篇 |
2016年 | 62篇 |
2015年 | 71篇 |
2014年 | 130篇 |
2013年 | 158篇 |
2012年 | 199篇 |
2011年 | 217篇 |
2010年 | 85篇 |
2009年 | 83篇 |
2008年 | 143篇 |
2007年 | 122篇 |
2006年 | 125篇 |
2005年 | 90篇 |
2004年 | 84篇 |
2003年 | 68篇 |
2002年 | 44篇 |
2001年 | 3篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 4篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 6篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1987年 | 1篇 |
排序方式: 共有2118条查询结果,搜索用时 46 毫秒
991.
Aviello G Romano B Borrelli F Capasso R Gallo L Piscitelli F Di Marzo V Izzo AA 《Journal of molecular medicine (Berlin, Germany)》2012,90(8):925-934
Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of Cannabis sativa, exerts pharmacological actions (antioxidant and intestinal antinflammatory) and mechanisms (inhibition of endocannabinoid enzymatic degradation) potentially beneficial for colon carcinogenesis. Thus, we investigated its possible chemopreventive effect in the model of colon cancer induced by azoxymethane (AOM) in mice. AOM treatment was associated with aberrant crypt foci (ACF, preneoplastic lesions), polyps, and tumour formation, up-regulation of phospho-Akt, iNOS and COX-2 and down-regulation of caspase-3. Cannabidiol-reduced ACF, polyps and tumours and counteracted AOM-induced phospho-Akt and caspase-3 changes. In colorectal carcinoma cell lines, cannabidiol protected DNA from oxidative damage, increased endocannabinoid levels and reduced cell proliferation in a CB(1)-, TRPV1- and PPARγ-antagonists sensitive manner. It is concluded that cannabidiol exerts chemopreventive effect in vivo and reduces cell proliferation through multiple mechanisms. 相似文献
992.
993.
Fabiana de Sousa Cunha Laise Nayra dos Santos Pereira Thâmara Pryscilla de Costa e Silva Roberto Alves de Sousa Luz 《Journal of drug targeting》2013,21(7):732-741
AbstractThe use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers, which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the present work is a review that examines some nanosystems with nanoparticles for action in the treatment of breast cancer and ovarian cancer. 相似文献
994.
Berlot G Vassallo MC Busetto N Bianchi M Zornada F Rosato I Tartamella F Prisco L Bigotto F Bigolin T Ferluga M Batticci I Michelone E Borelli M Viviani M Tomasini A 《Journal of critical care》2012,27(2):167-171
Purpose
Because the use of IgM and IgA enriched polyclonal intravenous immunoglobulins (eIg) is a standard of care in critically ill patients admitted to our intensive care unit (ICU) with the diagnosis of severe sepsis or septic shock, we investigated if the delay from the onset of severe sepsis and septic shock and their administration could influence the outcome.Materials and Methods
The medical records of all patients with severe sepsis or septic shock admitted to our ICU from July 2004 through October 2009 and treated with eIg (Pentaglobin®; Biotest, Dreieich, Germany) were retrospectively examined.Results
A total of 129 adult patients with severe sepsis or septic shock were considered eligible. Thirty-two percent of patients died during the ICU stay. Survivors were given eIg significantly earlier than nonsurvivors (23 vs 63 hours, P < .05). The delay in the administration of eIg and the Simplified Acute Physiology Score II were the only variables that entered stepwise a propensity score-adjusted logistic model. The delay in the administration of eIg was a significant predictor of the odds of dying during the ICU stay (odds ratio for 1 hour of delay, 1.007; P < .01; 99% confidence interval from 1.001 to 1.010) and proved to be independent from the Simplified Acute Physiology Score II and other variables.Conclusions
The efficacy of eIg, being maximal in early phases of severe sepsis and/or septic shock, is probably time dependent. 相似文献995.
Francesca Ungaro Ivana d'AngeloCiro Coletta Roberta d'Emmanuele di Villa BiancaRaffaella Sorrentino Brunella PerfettoMaria Antonietta Tufano Agnese MiroMaria Immacolata La Rotonda Fabiana Quaglia 《Journal of controlled release》2012,157(1):149-159
Although few experimental studies have been handled so far to exploit the potential of poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) in the production of dry powders for antibiotic inhalation, there has been no comprehensive study on the role played by NP composition. In this work, we try to shed light on this aspect by designing and developing a pulmonary delivery system for antibiotics, such as tobramycin (Tb), based on PLGA NPs embedded in an inert microcarrier made of lactose, referred to as nano-embedded micro-particles (NEM). At nanosize level, helper hydrophilic polymers were used to impart the desired surface, bulk and release properties to PLGA NPs prepared by a modified emulsion-solvent diffusion technique. Results showed that poly(vinyl alcohol) (PVA) and chitosan (CS) are essential to optimise the size and modulate the surface properties of Tb-loaded PLGA NPs, whereas the use of alginate (Alg) allows efficient Tb entrapment within NPs and its release up to one month. Optimized formulations display good in vitro antimicrobial activity against P. aeruginosa planktonic cells. Furthermore, spray-drying of the NPs with lactose yielded NEM with peculiar but promising flow and aerosolization properties, while preserving the peculiar NP features. Nonetheless, in vivo biodistribution studies showed that PVA-modified Alg/PLGA NPs reached the deep lung, while CS-modified NPs were found in great amounts in the upper airways, lining lung epithelial surfaces. In conclusion, PLGA NP composition appears to play a crucial role in determining not only the technological features of NPs but, once processed in the form of NEM, also their in vitro/in vivo deposition pattern. 相似文献
996.
de Matos GF Stanzani F Passos RH Fontana MF Albaladejo R Caserta RE Santos DC Borges JB Amato MB Barbas CS 《Critical care (London, England)》2012,16(1):R4
Introduction
The benefits of higher positive end expiratory pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS) have been modest, but few studies have fully tested the "open-lung hypothesis". This hypothesis states that most of the collapsed lung tissue observed in ARDS can be reversed at an acceptable clinical cost, potentially resulting in better lung protection, but requiring more intensive maneuvers. The short-/middle-term efficacy of a maximum recruitment strategy (MRS) was recently described in a small physiological study. The present study extends those results, describing a case-series of non-selected patients with early, severe ARDS submitted to MRS and followed until hospital discharge or death. 相似文献997.
998.
999.
1000.
Arvia R Corcioli F Simi L Orlando C De Santis R Facchini M Donatelli I Azzi A 《Journal of virological methods》2012,184(1-2):113-116
For the early detection of the H275Y mutation as a marker of oseltamivir resistance in A(H1N1) pandemic strains, a sensitive and specific pyrosequencing assay was developed. This assay analyses a region 99nts long, encompassing the H275Y site, amplified by a nested PCR. Seventy-five respiratory specimens, obtained from 62 patients during the pandemic and in the 2010-2011 influenza season, in Tuscany, were tested. Resistant strains were demonstrated in 10 patients. In three other patients, resistant and sensitive variants were found. This pyrosequencing assay may be a useful method for monitoring the spread of resistant influenza H1N1 2009 strains. 相似文献